Eagle Health Investments Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$571.8M
Q ending 2026-03-31
Prior quarter
$455.1M
Q ending 2025-12-31
Change
+25.7% QoQ · +48.5% YoY
Positions
28
reported holdings
Largest positions
All 28 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Spdr Series Trust | XBI | Put | $93.2M | 730K |
| Argenx Se | ARGX | Shares | $55.7M | 76K |
| Icon Plc | Shares | $39.7M | 359K | |
| Insmed Inc | INSM | Shares | $36.7M | 224K |
| Guardant Health Inc | GH | Shares | $28.7M | 310K |
| Biomarin Pharmaceutical Inc | BMRN | Shares | $28.6M | 506K |
| Natera Inc | NTRA | Shares | $24.4M | 122K |
| Scholar Rock Hldg Corp | SRRK | Shares | $24.3M | 494K |
| Illumina Inc | ILMN | Shares | $23.1M | 187K |
| Terns Pharmaceuticals Inc | 430 | Shares | $21.7M | 412K |
| Bridgebio Pharma Inc | BBIO | Shares | $19.8M | 267K |
| Ascendis Pharma A/S | Shares | $19.8M | 87K | |
| Protagonist Therapeutics Inc | PTGX | Shares | $18.9M | 179K |
| Ultragenyx Pharmaceutical In | RARE | Shares | $18.5M | 884K |
| Boston Scientific Corp | BSX | Shares | $18.4M | 293K |
| Fortrea Hldgs Inc | FTRE | Shares | $12.3M | 1.3M |
| Kymera Therapeutics Inc | KYMR | Shares | $12.1M | 146K |
| Procept Biorobotics Corp | PRCT | Shares | $12.1M | 484K |
| Revolution Medicines Inc | RVMD | Shares | $11.6M | 119K |
| Tempus Ai Inc | TEM | Shares | $11.6M | 256K |
| Compass Pathways Plc | CMPS | Shares | $11.4M | 2.1M |
| Centessa Pharmaceuticals Plc | 260 | Shares | $8.5M | 214K |
| Alkermes Plc | Shares | $8.4M | 239K | |
| Ataibeckley Inc | ATAI | Shares | $6.1M | 1.7M |
| Procept Biorobotics Corp | PRCT | Call | $2.3M | 90K |
| Intuitive Surgical Inc | ISRG | Shares | $2.0M | 4K |
| Immunocore Hldgs Plc | IMCR | Shares | $1.4M | 46K |
| Perceptive Cap Solutions Cor | Shares | $413K | 38K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.